Status:
COMPLETED
Comparing a Group-based Guided Self-help Approach to Pure Self-help for the Treatment of BED
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Binge Eating Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Binge eating disorder (BED) is the most common eating disorder in adults, affecting 2.8% of the population. The disorder is characterized by recurrent episodes of binge eating which are not followed b...
Eligibility Criteria
Inclusion
- Meets criteria for Diagnostic and Statistical Manual of Mental Disorders (5th Edition) diagnosis of BED (mild-extreme) as per Eating Disorder Examination - Mild severity will be modified from a minimum of 1 objective binge episode/week to 2 objective binge episodes per week
- Age 18 or older
- Access to computer with internet connection and webcam that can be used in a private area
- Virtually signed informed consent form
Exclusion
- Currently receiving psychotherapy/treatment for BED (as determined by PI)
- Self-reported Body Mass Index on pre-screening questionnaire \< 20 kg/m2
- Dose change of a psychotropic medication used for the treatment of BED (e.g., Vyvanse, topiramate, antidepressants) or any medication that could have an effect on appetite/binging (e.g., Saxenda) within 4 weeks of study inclusion (as determined by PI)
- Insufficient knowledge of English
- Previously participated in proof-of-concept BFT study
- Previously read Overcoming Binge Eating by C. Fairburn and implemented strategies presented in the book (as determined by PI)
- Serious physical illness (e.g., severe uncontrolled insulin dependent diabetes) (as determined by PI)
- Currently pregnant
- Scores greater than 20 on the Quick Inventory of Depressive Symptomatology Self-Report and PI determines participant is significantly depressed (as determined by PI)
- Currently experiencing serious issues with alcohol or drugs (as determined by PI)
- Currently engaging in self-harm behaviours (as determined by PI)
Key Trial Info
Start Date :
January 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2023
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT04432311
Start Date
January 5 2021
End Date
July 20 2023
Last Update
August 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nova Scotia Heath Authority
Halifax, Nova Scotia, Canada, B3H 2E2